These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, Gaksch M, Grübler M, Fahrleitner-Pammer A, Mrak P, Toplak H, Kraigher-Krainer E, März W, Pilz S. Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631 [Abstract] [Full Text] [Related]
3. Factors affecting parathyroid hormone levels in different types of primary aldosteronism. Jiang Y, Zhang C, Ye L, Su T, Zhou W, Jiang L, Zhang Y, Wang W. Clin Endocrinol (Oxf); 2016 Aug; 85(2):267-74. PubMed ID: 26589237 [Abstract] [Full Text] [Related]
4. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [Abstract] [Full Text] [Related]
5. Bone health and aldosterone excess. Ceccoli L, Ronconi V, Giovannini L, Marcheggiani M, Turchi F, Boscaro M, Giacchetti G. Osteoporos Int; 2013 Nov; 24(11):2801-7. PubMed ID: 23695421 [Abstract] [Full Text] [Related]
6. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. Maniero C, Fassina A, Seccia TM, Toniato A, Iacobone M, Plebani M, De Caro R, Calò LA, Pessina AC, Rossi GP. J Hypertens; 2012 Feb; 30(2):390-5. PubMed ID: 22179087 [Abstract] [Full Text] [Related]
7. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy. Lenzini L, Prisco S, Vanderriele PE, Lerco S, Torresan F, Maiolino G, Seccia TM, Iacobone M, Rossi GP. J Clin Endocrinol Metab; 2019 Sep 01; 104(9):3726-3734. PubMed ID: 30865228 [Abstract] [Full Text] [Related]
8. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. Rossi GP, Ragazzo F, Seccia TM, Maniero C, Barisa M, Calò LA, Frigo AC, Fassina A, Pessina AC. Hypertension; 2012 Aug 01; 60(2):431-6. PubMed ID: 22733469 [Abstract] [Full Text] [Related]
9. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, März W, Pieber TR, Tomaschitz A. J Clin Endocrinol Metab; 2012 Jan 01; 97(1):E75-9. PubMed ID: 22013107 [Abstract] [Full Text] [Related]
10. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals. Gao X, Yamazaki Y, Tezuka Y, Onodera Y, Ogata H, Omata K, Morimoto R, Nakamura Y, Satoh F, Sasano H. J Steroid Biochem Mol Biol; 2019 Oct 01; 193():105434. PubMed ID: 31351131 [Abstract] [Full Text] [Related]
11. Hyperparathyroidism in patients with overt and mild primary aldosteronism. Gravvanis C, Papanastasiou L, Glycofridi S, Voulgaris N, Tyfoxylou E, Theodora K, Piaditis G, Markou Α. Hormones (Athens); 2021 Dec 01; 20(4):793-802. PubMed ID: 34524646 [Abstract] [Full Text] [Related]
12. Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels. Tuersun T, Luo Q, Zhang Z, Wang G, Zhang D, Wang M, Wu T, Zhou K, Yue N, Li N. Hypertens Res; 2020 Dec 01; 43(12):1413-1420. PubMed ID: 32770102 [Abstract] [Full Text] [Related]
13. Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study. Kometani M, Yoneda T, Aono D, Gondoh-Noda Y, Matsuoka T, Higashitani T, Yoshikura S, Sawada K, Takeda Y, Fujimoto A, Karashima S, Usukura M, Takeda Y. Intern Med; 2021 Dec 01; 60(7):993-998. PubMed ID: 33790140 [Abstract] [Full Text] [Related]
14. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Brown JM, Williams JS, Luther JM, Garg R, Garza AE, Pojoga LH, Ruan DT, Williams GH, Adler GK, Vaidya A. Hypertension; 2014 Feb 01; 63(2):273-80. PubMed ID: 24191286 [Abstract] [Full Text] [Related]
15. Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry. Asbach E, Bekeran M, König A, Lang K, Hanslik G, Treitl M, Ladurner R, Bidlingmaier M, Beuschlein F, Quinkler M, Reincke M. Exp Clin Endocrinol Diabetes; 2020 Apr 01; 128(4):246-254. PubMed ID: 31698477 [Abstract] [Full Text] [Related]
16. The FGF-23/klotho axis and its relationship with phosphorus, calcium, vitamin D, PTH, aldosterone, severity of disease, and outcome in hospitalised foals. Kamr AM, Dembek KA, Hildreth BE, Morresey PR, Rathgeber RA, Burns TA, Zaghawa AA, Toribio RE. Equine Vet J; 2018 Nov 01; 50(6):739-746. PubMed ID: 29660161 [Abstract] [Full Text] [Related]
17. Deficiency of vitamin D and elevated aldosterone in prostate hyperplasia. Yalçınkaya S, Eren E, Eroglu M, Aydin O, Yilmaz N. Adv Clin Exp Med; 2014 Nov 01; 23(3):441-6. PubMed ID: 24979517 [Abstract] [Full Text] [Related]
18. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. Brown JM, Vaidya A. Curr Opin Endocrinol Diabetes Obes; 2014 Jun 01; 21(3):193-201. PubMed ID: 24694551 [Abstract] [Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
20. Parathyroid Gland Function in Primary Aldosteronism. Asbach E, Bekeran M, Reincke M. Horm Metab Res; 2015 Dec 01; 47(13):994-9. PubMed ID: 26667802 [Abstract] [Full Text] [Related] Page: [Next] [New Search]